Skip to main content
Premium Trial:

Request an Annual Quote

Knome Lands Two Customers for Whole-Genome Sequencing

NEW YORK (GenomeWeb News) — The personal whole genome startup company Knome said today it has lined up the first two customers for its DNA sequencing and analysis service, which it offers through a partnership with the Beijing Genomics Institute.
Knome said the two individuals would be the first in the world to have their genomes sequenced by a personal genomics firm.
J. Craig Venter and James Watson were the first humans to have their genomes sequenced as part of sponsored research efforts, Knome noted, and recently BGI said it performed a full sequencing on a Chinese scientist who will remain anonymous.
Knome VP of Sales and Business Development Ari Kiirikki said the two individuals have chosen to remain anonymous as well, adding that the company’s service includes “a variety of processes and tools to keep their genomic identity private and secure.”
Cambridge, Mass.-based Knome is marketing its whole-genome sequencing and genomic analysis, which costs around $350,000, to an initial group of about 20 customers worldwide.
“Whole-genome sequencing represents the future of personalized medicine and these sequenced genomes will nearly double the amount of whole-genome information available today,” said George Church, a founder of the company and a genetics professor at Harvard Medical School.
Zhuo Li, BGI’s VP of international collaboration, said the firm expects to complete the sequencing for the two clients sometime “in the coming months.”
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.